Atomoxetine Inhibitor

MBS5756575 is an inhibitor targeting Atomoxetine. Atomoxetine is a selective inhibitor of noradrenaline reuptake.

Mosholder AD, Taylor L, Mannheim G, Ortendahl L, Woodworth TS, Toh S. Incidence of Heart Failure and Cardiomyopathy Following Initiation of Medications for Attention-Deficit/Hyperactivity Disorder: A Descriptive Study. J Clin Psychopharmacol. 2018 Aug 10. doi: 10.1097/JCP.0000000000000939. [Epub ahead of print] PubMed PMID: 30102629.
Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Atkinson LZ, Tessari L, Banaschewski T, Coghill D, Hollis C, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018 Aug 7. pii: S2215-0366(18)30269-4. doi: 10.1016/S2215-0366(18)30269-4. [Epub ahead of print] PubMed PMID: 30097390.
Froehlich T, Fogler J, Barbaresi WJ, Elsayed NA, Evans SW, Chan E. Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review. Clin Pharmacol Ther. 2018 Jul 27. doi: 10.1002/cpt.1192. [Epub ahead of print] Review. PubMed PMID: 30053315.
van den Brink RL, Nieuwenhuis S, Donner TH. Amplification and Suppression of Distinct Brain-wide Activity Patterns by Catecholamines. J Neurosci. 2018 Jul 23. pii: 0514-18. doi: 10.1523/JNEUROSCI.0514-18.2018. [Epub ahead of print] PubMed PMID: 30037827.

Small volumes of Atomoxetine, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.